The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sun exposure and associated risks: Insight from an international survey with a focus on the organ transplant recipient population.
 
Delphine Kerob
Employment - La Roche-Posay/L'Oreal
Leadership - L'Oreal
Stock and Other Ownership Interests - L'Oreal
Honoraria - L'Oreal
Research Funding - L'Oreal (Inst)
 
Brigitte Dreno
Consulting or Advisory Role - Almirall; Bristol-Myers Squibb; Pierre Fabre; Roche/Genentech; Sun Pharma
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech
 
Thierry Passeron
Honoraria - Abbvie; ACM Pharma; Almirall; Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Galderma; Genzyme; GlaxoSmithKline; Incyte; Janssen; Leo Pharma; Lilly O.; Novartis; Pfizer; Sanofi; Sun Pharma
Consulting or Advisory Role - Abbvie; Almirall; Amgen; Bristol-Myers Squibb; Galderma; Incyte; Janssen; Lilly O.; Novartis; UCB
Research Funding - Bristol-Myers Squibb (Inst); Genzyme (Inst); Incyte (Inst); Leo Pharma (Inst); Lilly O. (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patent rights on the use of CXCR3B, WNT agonists and GSK3b in the treatment of vitiligo
Travel, Accommodations, Expenses - Abbvie; Incyte; Janssen; Leo Pharma; Lilly O.; Novartis; UCB
Other Relationship - Yukin Therapeutics
 
Susana Puig
Honoraria - Almirall; Bristol-Myers Squibb/Celgene; Canfield Scientific (I); ISDIN; La Roche Posay; MSD; Novartis; Pfizer; Pierre Fabre (I); Regeneron; Roche; Sanofi; Sun Pharma
Consulting or Advisory Role - Almirall; Roche; Sanofi; Sun Pharma
Research Funding - Almirall (I); ISDIN; La Roche Posay
Travel, Accommodations, Expenses - Almirall; ISDIN; La Roche Posay
 
Cl Goh
Consulting or Advisory Role - Galderma; La Roche-Posay
Speakers' Bureau - Galderma
Travel, Accommodations, Expenses - Neoasia
 
Henry Lim
Consulting or Advisory Role - Beiersdorf; Isdin; La Roche Posay; Pierre Fabre
Research Funding - Incyte (Inst); La Roche Posay (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - ISDIN
 
Fatimata Ly
Travel, Accommodations, Expenses - La Roche Posay
 
H. Kang
Honoraria - La Roche Posay
Consulting or Advisory Role - La Roche Posay
Research Funding - Viol, Chanel (Inst)
 
A. Morita
Consulting or Advisory Role - L'Oreal
 
Jorge Ocampo
Honoraria - Isdin; L'Oreal
Consulting or Advisory Role - Isdin; L'Oreal
Speakers' Bureau - Isdin; L'Oreal
Research Funding - Abbvie (Inst); Boehringer Ingelheim (Inst); Lilly O. (Inst); Novartis (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Uriage
 
Sergio Schalka
Honoraria - FQM; Isdin; La Roche-Posay; NAOS
Consulting or Advisory Role - FQM; Isdin; La Roche-Posay; NAOS
Speakers' Bureau - FQM; La Roche-Posay; NAOS
Travel, Accommodations, Expenses - FQM; Isdin; La Roche-Posay; NAOS
 
L. Wei
Honoraria - L'Oreal; Symrise
Consulting or Advisory Role - L'Oreal; Symrise
Speakers' Bureau - L'Oreal; Symrise
 
Caroline Lefloch
Employment - La Roche-Posay/L'Oreal
 
Anne-Laure Demessant
Employment - La Roche-Posay/L'Oreal
 
Jean Krutmann
No Relationships to Disclose